Centre Hospitalier Lyon Sud; Dermatologie

Pierre-Bénite 69495

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Basal Cell Carcinoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma — Completed
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis — Completed